Physician profile
Gary Blick
NPI 1598837957
$683,350.98
in general payments reported to CMS, 2019-2025
12 companies · $72K in 2025
The $72K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $66K · 2021: $74K · 2022: $92K · 2023: $128K · 2024: $144K · 2025: $72K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $291K · Travel and Lodging: $36K · Consulting Fee: $9,100 · Food and Beverage: $8,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $291,200.00 |
| Travel and Lodging | $36,306.17 |
| Consulting Fee | $9,100.00 |
| Food and Beverage | $8,152.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $681,558.96 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Glaxosmithkline, LLC. | $1,107.23 | 2019-2025 | Arexvy, Shingrix |
| Emd Serono, INC. | $231.64 | 2019-2025 | Serostim |
| Janssen Products, Lp | $101.48 | 2019-2021 | |
| Janssen Biotech, INC. | $89.70 | 2019 | |
| Theratechnologies INC. | $65.32 | 2019 | |
| Antares Pharma, INC. | $64.93 | 2019-2025 | Xyosted |
| Abbvie INC. | $44.37 | 2022-2023 | Qulipta |
| Merck Sharp & Dohme LLC | $34.04 | 2019 | |
| Amgen INC. | $21.04 | 2019 | |
| Novo Nordisk INC | $18.61 | 2019 | |
| Napo Pharmaceuticals INC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Blick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.